Pharmafile Logo

Research Partnership’s Singapore team relocates to new office

We are delighted to announce that our Asia-Pacific team in Singapore has relocated to new premises.

Research Partnership’s Singapore office is the largest independent specialist healthcare agency in the region and is led by Director Pei Li Teh. The office was established in 2007, and in the 10 years since it opened the team has conducted in excess of 200 health market research studies both qualitative and quantitative, across 47 therapy areas covering virtually every market in the Asia Pacific region.

In 2016/17 the office conducted over 50 projects, welcomed a number of new hires and represented Research Partnership at various industry events including the Pharma China Annual Forum 2017 where Pei Li presented the paper  ’Urban China’s Evolving Patient Journey.’ 

Find out more https://www.researchpartnership.com/news/2017/06/research-partnership%E2%80%99s-singapore-team-reloc…

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Infographic: Spondyloarthritis

Overview of spondyloarthritis patient profiles and treatment pathways.

Webinar: Demand assessment – Reflecting real world choices

How study design which reflects doctors’ real world choices can optimise results.

Evaluating the potential of a pre-launch prodct in a real-life setting

Using in-depth-interviews as well as a SmartPhone app to collect real patient cases from physicians to find out opportunity for a new product.

Competition from within

Published in eyeforpharma July 29 by Rachel Howard

Infographic: RA Perceptions

HCPs predict the future of the biologics market

From chaos to calm: how to make sense of social media

What do you know about chaos theory?

Breaking Down the Barriers to Effective Treatment of Hepatitis C in Latin America

Published in eyeforpharma June 9 by Rachel Howard and Raquel Nunez.

Infographic: HCV LATAM

An introduction to the HCV LATAM patient.

Spotlight on Saudi Arabia

Published in eyeforpharma 20 May by Rachel Howard